Multitargeted Anti-Infective Drugs: Resilience to Resistance in the Antimicrobial Resistance Era
Future Drug Discovery · 2022-03 · 4 (1)
DOI: 10.4155/fdd-2022-0001 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Future Drug Discovery, online erschienen am 05.05.2022. Verfasst von Colin J Suckling und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pure & Applied Chemistry, University of Strathclyde, 295 Cathedral Street, Glasgow, G1 1XL, UK. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chief Scientist's Office, Wellcome Trust, Medical Research Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pure & Applied Chemistry, University of Strathclyde, 295 Cathedral Street, Glasgow, G1 1XL, UK.
- Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow, G4 0RE, UK.
ORCID-Profile: Colin J Suckling, Iain S Hunter, Fraser J Scott
Förderung
- Chief Scientist's Office
- Wellcome Trust
- Medical Research Council
- Biotechnology and Biological Sciences Research Council
Zitieren
APA
Suckling, C. J., Hunter, I. S., & Scott, F. J. (2022). Multitargeted Anti-Infective Drugs: Resilience to Resistance in the Antimicrobial Resistance Era. Future Drug Discovery, 4(1). https://doi.org/10.4155/fdd-2022-0001
Vancouver
Suckling CJ, Hunter IS, Scott FJ. Multitargeted Anti-Infective Drugs: Resilience to Resistance in the Antimicrobial Resistance Era. Future Drug Discovery. 2022;4(1). doi:10.4155/fdd-2022-0001
BibTeX
@article{Suckling2022,
author = {Suckling, Colin J and Hunter, Iain S and Scott, Fraser J},
title = {Multitargeted Anti-Infective Drugs: Resilience to Resistance in the Antimicrobial Resistance Era},
journal = {Future Drug Discovery},
year = {2022},
volume = {4},
number = {1},
doi = {10.4155/fdd-2022-0001}
}
EUVIMED